NCT06655545已完成不适用
A Single-center, Real-world Study Exploring the Guidance of FES-PET for First-line Treatment of HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 473
- 试验地点
- 1
- 主要终点
- PFS
研究概览
简要总结
A single-center, real world study to evaluate the role of FES-PET in guiding the first-line treatment of HR+/HER2- MBC patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •age >= 18 years old;
- •Patients who were diagnosed as HR Positive, HER2 Negative recurrent unresectable (local or regional) or stage IV (M1) breast cancer between January 2020 to February 2024;
- •Received CDK4/6 inhibitor plus endocrine treatment or chemotherapy as first-line therapy for at least one cycle;
- •Complete medical history was available.
排除标准
- •Medical history was incomplete.
结局指标
主要结局
PFS
时间窗: 6 weeks
progression-free survival
次要结局
- OS(6 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
A prospective single-centre study to assess the effectiveness of Closed-Loop Spinal Cord Stimulation (CL-SCS) in the treatment of chronic pain associated with primary and secondary Raynaud's PhenomenoDRKS00030179niversitätsklinikum Bonn10
Unknown
4 期
Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer PatientsAdvanced Pancreatic CancerNCT04217096Fudan University40
已完成
不适用
Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients with Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT）PsoriasisNCT05863273First Hospital of China Medical University360
招募中
不适用
Efficacy and Safety of CSA and Avatrombopag for the Treatment of SAA in the ElderlySevere Aplastic AnemiaNCT05433922Institute of Hematology & Blood Diseases Hospital, China80
已完成
1 期
Practical evaluation of PET studies with [18F]-GE180, [18F]-FDOPA and [18F]-FLT for a future clinical trial of iPSC-based cell therapy in Parkinson's diseaseneuroinflammatory disorder, Parkinson's disease, Brain tumorJPRN-UMIN000030084Kyoto University12